A study has found that an anti-inflammatory drug, normally used for rheumatoid arthritis, may help ease symptoms of treatment-resistant depression. It adds that targeting the immune system, rather than only brain chemistry, could offer a new path for people who do not respond to standard antidepressants.
No comments:
Post a Comment